4.7 Article

Defining post-stroke recovery: implications for design and interpretation of drug trials

期刊

NEUROPHARMACOLOGY
卷 39, 期 5, 页码 835-841

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0028-3908(00)00003-4

关键词

stroke; outcomes; recovery

资金

  1. NIA NIH HHS [P60 AG 14635-02] Funding Source: Medline
  2. NATIONAL INSTITUTE ON AGING [P60AG014635] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Measurement of stroke recovery is complex because definition of successful recovery is highly variable across measures and cutoff points for defining successful outcomes vary. The purpose of this paper is to describe patterns of recovery in stroke patients of varying severity when different measures are used and when different cut-off points are selected. 459 individuals enrolled in a prospective cohort study were assessed within 14 days post stroke and re-evaluated at 1, 3, and 6 months. Recovery was assessed using the NIH Stroke Scale, the Fugl-Meyer Assessment of Motor Recovery, the Barthel Index of Activities of Daily Living, the Physical Function Index of the SF-36, and the Modified Rankin Outcome Scale. Subjects also defined their preference (utility) for their current health state with a time-trade off question. We compared patterns of recovery using the different measures and varying the cut-off points for defining successful recovery. The percentage of patients who are believed to have recovered depends on how recovery is defined. If recovery is defined at the disability level (Barthel>90), the majority 57.3% of stroke survivors experience a full recovery. Fewer individuals are considered to be fully recovered if impairments are measured (NIH less than or equal to 1, 44.9% and Fugl-Meyer>90, 36.8%. Less than 25% of stroke survivors are considered recovered if recovery is defined relative to reported prior function in higher levels of physical activity. Shifting the definition of recovery on the modified Rankin scale from less than or equal to 1 to less than or equal to 2 shifts the percentage of those deemed recovered from less than or equal to 25% to 53.8%. In designing drug trials the methods for defining stroke recovery should be carefully considered. If recovery is defined in terms of disability, a higher proportion of the placebo group will achieve the outcome than if impairments are used to define recovery. The benchmarks for recovery in minor strokes must include measures of higher functioning (e.g. the SF-36 physical functioning index or a Rankin 0 (no symptoms). (C) 2000 Published by Elsevier Science Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据